期刊文献+

Th1/Th2细胞因子在初发型溃疡性结肠炎治疗前后的血清水平变化 被引量:6

The Changes of Serum Levels of Th1/Th2 Cytokines before and after the Treatment of Active Ulcerative Colitis
下载PDF
导出
摘要 目的:观察溃疡性结肠炎(UC)治疗前后血清Th1/Th2细胞因子的水平变化。方法:将初发型UC患者58例作为UC组,选取同期健康人58例作为对照组,在治疗前及治疗3月、12月3个时间点检测血清中IL-2、IFN-γ、IL-4、IL-10表达水平。结果:治疗前,UC组患者血清IFN-γ、IL-10水平明显降低,IL-4水平明显升高,均有统计学差异(P<0.05)。治疗3月及12月,UC组IFN-γ水平仍明显低于对照组,但UC组前后无差异;IL-4水平明显高于对照组,且治疗12月IL-4水平较治疗3月时显著降低(P<0.05);IL-10水平明显低于对照组,但治疗12月IL-10水平较治疗3月时显著升高(P<0.05)。UC组与对照组治疗前后IL-2水平无差异性变化(P>0.05)。结论:我们推测UC活动期血清IFN-γ表达下调、IL-4表达上调,一定程度抑制Th1细胞免疫反应,抑制炎症进展。随着UC病情缓解,血清IL-10表达上调、IL-4表达下调,逐渐恢复Th1/Th2细胞平衡。 Objective: To observe the changes of serum levels of Th1/Th2 cytokin before and after the treatment of ulcerative colitis( UC). Methods: 58 patients with active UC were selected into UC group while58 healthy persons as control group. The expression of IL-2、IFN-γ、IL-4、IL-10 in serum were measured at the 3 different time points: before treatment,3 months and 12 months after treatment. Results: Before treatment,the expression of IFN-γ、IL-10 in serum decreased but IL-4 increased in UC group,with statistical differences( P〈0.05). 3 months and 12 months after treatment,the expression of IFN-γ in UC group was lower significantly than control group,but no statistical difference was found in UC group. The expression of IL-4 was higher significantly than control group,especially at the time point of 12 months after treatment( P〈0.05). The expression of IL-10 was lower than control group,but it increased significantly at the time point of12 months after treatment( P〈0.05). There was no statistical difference in the expression of IL-2 between the two groups( P〈0.05). Conclusion: It was suggested that the expression of IFN-γ decreased and IL-4 increased in serum during active UC,would inhibit the Th1 cells immune response to limit inflammatory process.During the remission of UC,the expression of IL-4 decreased and IL-10 increased would keep the balance of Th1/Th2 cells gradually.
出处 《河北医学》 CAS 2018年第1期167-170,共4页 Hebei Medicine
基金 2015年江门市科技计划项目 (编号:江科[2015]73号)
关键词 溃疡性结肠炎 TH1/TH2细胞因子 炎症 Ulcerative colitis Th1/Th2 cytokines Inflammation
  • 相关文献

参考文献2

二级参考文献111

  • 1Rutgeerts P, Vermeire S, Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 2009; 136: 1182-1197.
  • 2Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957; 147:258-267.
  • 3Armstrong AM, Gardiner KR, Kirk SJ, Halliday MI, Rowlands BJ. Tumour necrosis factor and inflammatory bowel disease. Br J Surg 1997; 84:1051-1058.
  • 4Scaldaferri F, Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis 2007; 8:171-178.
  • 5Targan SR, Karp LC. Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev 2005; 206:296-305.
  • 6Hvas CL, Kelsen J, Agnholt J, Hollsberg P, Tvede M, Moller JK, Dahlerup JF. Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria. Scand J Gastroentero12007; 42:592-601.
  • 7Saruta M, Yu QT, Fleshner PR, Mantel PY, Schmidt-Weber CB, Banham AH, Papadakis KA. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. Clin Immunol 2007; 125:281-290.
  • 8Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S. Type I T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol1997; 150:823-832.
  • 9Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441:231-234.
  • 10McGeachy MJ, Cua DJ. The link between IL-23 and Th17 cell-mediated immune pathologies. Semin Immunol 2007; 19: 372-376.

共引文献75

同被引文献92

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部